# FGF23 as a Marker of Acute Kidney Injury

> **NCT04693962** · — · UNKNOWN · sponsor: **University of Chile** · enrollment: 40 (estimated)

## Conditions studied

- Acute Kidney Injury
- Kidney Ischemia

## Interventions

- **DIAGNOSTIC_TEST:** Plasmatic Fibroblast Growth Factor-23 by means of ELISA

## Key facts

- **NCT ID:** NCT04693962
- **Lead sponsor:** University of Chile
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-04-01
- **Primary completion:** 2020-05-30
- **Final completion:** 2021-12-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2021-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04693962

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04693962, "FGF23 as a Marker of Acute Kidney Injury". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04693962. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*